Insiders who reported open-market trades in the last 12 months at the companies Jeetinder Singh Mahal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jeetinder Singh Mahal is a corporate insider, tracked as CEO and President, Director of Jasper Therapeutics, Inc. (JSPR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jeetinder Singh Mahal last file a Form 4?
The most recent primary Form 4 on record is dated 10 February 2026, one of 3 filings going back to 2024.
Has Jeetinder Singh Mahal been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($20K) across all tracked filings.
Jeetinder Singh Mahal is CEO and President, Director of Jasper Therapeutics, Inc. (JSPR). 3 SEC Form 4 filings on record going back to 2024, most recently on 10 February 2026. Most recent open-market trade: sold $20K of JSPR on 12 December 2024. Lifetime open-market sales: $20K.
Recent transactions
2
The latest 2 SEC Form 4 transactions reported by Jeetinder Singh Mahal.
InsiderAlpha's records for Jeetinder Singh Mahal go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. 3 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
